GOAL.MD vs Luvo Health
Neither GOAL.MD nor Luvo Health has an FDA warning letter on record. On brand-name semaglutide pen, GOAL.MD costs $12,060 less a year at standing rates: $294 a month against $1,299 a month at Luvo Health. It is one of three products the two sell at comparable terms.
The record
GOAL.MD / Luvo Health
GOAL.MD
8.0/10
Featured pick (affiliate partner)
Luvo Health
7.7/10
Luvo Health is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. GOAL.MD pays us nothing. The scores are computed the same way for both and are shown as computed (GOAL.MD 8.0, Luvo Health 7.7). How we are paid
What the record shows
- 01
Neither GOAL.MD nor Luvo Health has an FDA warning letter on record.
- 02
Neither names the pharmacy that compounds its medication.
- 03
On brand-name semaglutide pen, GOAL.MD costs $12,060 less a year at standing rates: $294 a month against $1,299 a month at Luvo Health. It is one of three products the two sell at comparable terms.
- 04
Only GOAL.MD lists a price for brand-name semaglutide pill. Only Luvo Health lists a price for compounded oral semaglutide.
- 05
GOAL.MD lists all 50 states. Luvo Health publishes no state list.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
GOAL.MD
Luvo Health
$179/mo
$2,148 a year
$179/mo
$2,148 a year
$249/mo
$2,988 a year
$179/moLower
$2,327 a year, 13 charges
$294/moLower
$3,528 a year
$1,299/mo
$15,588 a year
$394/moLower
$4,728 a year
$1,399/mo
$16,788 a year
$259/mo
$3,108 a year
$244/mo
$2,928 a year
Read off each seller’s own pages. GOAL.MD: October 17, 2026. Luvo Health: October 17, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for GOAL.MD
8.0/10- $12,060 a year less on brand-name semaglutide pen
- $12,060 a year less on brand-name tirzepatide pen
- Sells brand-name semaglutide pill, which Luvo Health does not price
- Names no compounding pharmacy
The case for Luvo Health
7.7/10- $661 a year less on compounded tirzepatide injection
- Sells compounded oral semaglutide, which GOAL.MD does not price
- Names no compounding pharmacy
- Publishes no state list
Scores
GOAL.MD 8.0 · Luvo Health 7.7 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
GOAL.MD vs Luvo Health: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Embody9.3
From $79/mo
Visit site - YourEra9.0
From $99/mo
Visit site - Gala8.4
From $179/mo
Visit site
Sellers closest to these two
- GOAL.MD vs Noom
- GOAL.MD vs Gala
- GOAL.MD vs Aquivia Health
- Luvo Health vs Noom
- Luvo Health vs Gala
- Luvo Health vs Aquivia Health
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks